Yuriko Fukuta, MD, PhD, CWSP
Picture
Positions
- Associate Professor
-
Baylor College of Medicine
Houston, Texas United States
Addresses
- Baylor College of Medicine Medical Center - McNair Campus (Clinic)
-
7200 Cambridge Street
8th Floor, Suite 8B
Houston, TX 77030
United States
Phone: (713) 798-2900
Education
- MD from Yokohama City University
- 03/2003 - Yokohoma, Japan
- Residency at University of Pittsburgh Medical Center
- 07/2010 - Shadyside
- Internal Medicine
- Fellowship at University of Pittsburgh
- 06/2012 - Pittsburgh
- Infectious Diseases
- PhD from Yokohama City University
- 02/2017 - Yokohama, Japan
- Residency at Teine Keijinkai Hospital
- 03/2006 - Sapporo, Japan
- Residency at Teine Keijinkai Hospital
- 03/2006 - Sapporo, Japan
- Chief Resident
- Fellowship at Teine Keijinkai Hospital
- 03/2007 - Sapporo, Japan
- Nephrology
Certifications
- American Board of Internal Medicine
- American Board of Infectious Diseases
- American Board of Wound Management
- American Board of Wound Management
Professional Statement
My mission is to provide the best Infectious Diseases care for all patients regardless socioeconomic status.Websites
Founder and President
Videos
Finalist in the 2022 Physician Enterprise National Abstract Competition Category: Clinical Research, Common Spirits
Selected Publications
- "Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern." 2022 Apr; Pubmed PMID: 35443020
- "Early Outpatient Treatment for Covid-19 with Convalescent Plasma." N Eng J Med. 2022 May 5;386:1700-1711. Pubmed PMID: 35353960
- "How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?." Transfusion. 2022 May;62:933-941. Pubmed PMID: 35352362
- "Joint Initiative Between Infectious Diseases and Podiatry in Outpatient Settings Improves Outcomes and Adherence to Treatment." Adv Skin Wound Care. 2021 Apr;34:210-213. Pubmed PMID: 33230022
- Levine AC, Fukuta Y, Huaman MA, Ou J, Meisenberg BR, Patel B, Paxton JH, Hanley DF, Rijnders BJ, Gharbharan A, Rokx C, Zwaginga JJ, Alemany A, Mitj? O, Ouchi D, Millat-Martinez P, Durkalski-Mauldin V, Sullivan DJ, et al "COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials.." Clin Infect Dis. 2023 Feb; Pubmed PMID: 36809473
- Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B, Gebo K, Cachay E, Kassaye SG, Paxton JH, Gerber J, Levine AC, Naeim A, Currier J, Patel B, Allen ES, Anjan S, Appel L, Baksh S, Blair PW, Bowen A, Broderick P, Caputo CA, Fukuta Y, Sullivan DJ, et al. "Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.." Clin Infect Dis. 2023 Feb;76(3):e477-e486. Pubmed PMID: 35579509
- Chiu CY, Amenta E, Chavez V, Fukuta Y, Hasbun R "Undetectable JC virus CSF PCR in patients with JC virus-induced progressive multifocal leukoencephalopathy." J Neurovirol. 2023; Pubmed PMID: 36723823
- Fukuta Y, Chua H, Phe K, Poythress EL, Brown CA "Infectious Diseases Management in Wound Care Settings: Common Causative Organisms and Frequently Prescribed Antibiotics.." Adv Skin Wound Care. 2022 Oct;35(10):535-543. Pubmed PMID: 36125453
- Fukuta Y, Wu CQ, Lasco TM, Diwan AH. "Skin Lesions, Weight Loss, and Facial Swelling After a Hand Injury.." Clin Infect Dis. 2024 Dec 17;79(6):1521-1523. Pubmed PMID: 39008337
Projects
- Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)
- (08/2020 - 03/2022)
- Convalescent Plasma to Stem Coronavirus (CSSC-001)
- (08/2020 - 03/2022)
- IUCRC Phase I Baylor College of Medicine: Center to Stream Healthcare In Place (C2SHIP)
- (04/2021 - present)
- Improving the science of adherence reinforcement and safe mobility in people with diabetic foot ulcers using smart offloading
- (01/2021 - present)
- Bridging the Gap: Addressing Disparities in Healthcare Literacy through Education and Technology
- (08/2022 - present)
Funding
- The microbiology and clinical outcomes of moderate to severe acute respiratory infections in hospitalized adults after the COVID-19 pandemic (08/01/2024 Pfizer
Languages
Japanese
Log In to edit your profile
